RepliCel's Manufacturing Inspected by Japan's PMDA

Author's Avatar
Jul 28, 2022

After over a year of pandemic-related delays, representatives of Japan's PMDA, attended at the Company's contract manufacturing facility, Innovacell, to review the manufacturing of RepliCel's NBDS cell therapy products